AA
AMPH icon

ALPS Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

ALPS Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,431
Closed -$440K – 1041
2025
Q4 		$440K Buy
16,431
+181
+1% +$4.66K ﹤0.01% 828
2025
Q3 		$433K Buy
+16,250
New +$420K ﹤0.01% 863
2025
Q1 		– Sell
-7,395
Closed -$275K – 1001
2024
Q4 		$275K Hold
7,395
– – ﹤0.01% 941
2024
Q3 		$359K Sell
7,395
-494
-6% -$21.7K ﹤0.01% 826
2024
Q2 		$316K Sell
7,889
-39
-0.5% -$1.62K ﹤0.01% 822
2024
Q1 		$348K Buy
7,928
+1,717
+28% +$88.7K ﹤0.01% 842
2023
Q4 		$384K Sell
6,211
-355
-5% -$18.6K ﹤0.01% 704
2023
Q3 		$302K Sell
6,566
-2,325
-26% -$127K ﹤0.01% 880
2023
Q2 		$511K Buy
8,891
+65
+0.7% +$2.88K ﹤0.01% 611
2023
Q1 		$331K Sell
8,826
-2,075
-19% -$68K ﹤0.01% 749
2022
Q4 		$305K Sell
10,901
-53
-0.5% -$1.54K ﹤0.01% 872
2022
Q3 		$308K Buy
+10,954
New +$358K ﹤0.01% 736
2017
Q3 		– Sell
-39,250
Closed -$701K – 780
2017
Q2 		$701K Buy
39,250
+101
+0.3% +$1.6K ﹤0.01% 293
2017
Q1 		$568K Buy
39,149
+15,820
+68% +$249K ﹤0.01% 307
2016
Q4 		$430K Buy
23,329
+221
+1% +$4.3K ﹤0.01% 535
2016
Q3 		$438K Buy
+23,108
New +$419K ﹤0.01% 370

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

ALPS Advisors's AMPH Position: Q1 2026 in Review

ALPS Advisors sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2026, closing a stake of 16,431 shares — an estimated $440K sold.

ALPS Advisors first reported a position in AMPH in Q3 2016 and held it in 16 quarters. The position peaked at $701K in Q2 2017. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • ALPS Advisors reported no remaining Amphastar Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • ALPS Advisors sold 16,431 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $440K.
  • ALPS Advisors first reported a position in Amphastar Pharmaceuticals in Q3 2016 and held it in 16 quarters.
  • ALPS Advisors's Amphastar Pharmaceuticals position peaked at $701K in Q2 2017.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.